Related Experiment Video
Updated: Aug 25, 2026

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
Published on: November 8, 2015
Experience with cyclosporine in pediatric renal transplantation
1Nephrourology Unit, Great Ormond Street Hospital for Children NHS Trust, London, UK.
Insights
Cyclosporine (CsA) is crucial for pediatric renal transplants but causes side effects. Monitoring drug levels optimizes outcomes and manages adverse events in children receiving kidney transplants.
Area of Science:
- Pediatric Nephrology
- Transplantation Immunology
Background:
- Renal transplantation is established for pediatric end-stage renal disease.
- Cyclosporine (CsA) became a cornerstone immunosuppressant in the 1980s.
- CsA is vital for preventing rejection in pediatric kidney recipients.
Purpose of the Study:
- To explore the role of Cyclosporine (CsA) in pediatric renal transplantation.
- To highlight the importance of managing CsA's adverse effects.
- To emphasize therapeutic drug monitoring for optimal outcomes.
Main Methods:
- Review of clinical immunosuppressive protocols involving CsA.
- Analysis of adverse effects associated with CsA therapy.
- Discussion of therapeutic drug level monitoring strategies.
Main Results:
- CsA has been central to successful pediatric renal transplant protocols.
- Adverse effects include hypertension, hyperlipidemia, nephrotoxicity, hirsutism, and gum hyperplasia.
- Cosmetic side effects significantly impact pediatric patient compliance.
Conclusions:
- CsA remains critical in pediatric renal transplantation.
- Careful monitoring and management of side effects are essential.
- Therapeutic drug level monitoring is key to optimizing clinical outcomes and ensuring graft survival.
Abstract:
Three decades ago renal transplantation had become the accepted therapy for end-stage renal disease in children. Cyclosporine (CsA) was introduced into the majority of clinical immunosuppressive protocols in the 1980s and attained a vital place in the armamentarium of antirejection drugs for children. However, CsA therapy is not without adverse effects, notably posttransplant hypertension, hyperlipidemia, and nephrotoxicity. The cosmetic side effects of CsA, principally hirsutism and gum hyperplasia, are significant and very important to children particularly when drug compliance issues are vital to achieve success. The central role CsA has played to date in the development of successful treatment protocols for children undergoing renal transplantation is explored, including the importance of therapeutic drug level monitoring to optimize clinical outcomes.
Related Concept Videos
Kidney Transplant II: Surgical Procedure
Pharmacokinetics in Pediatric Patients: Drug Excretion
Kidney Transplant I: Introduction
Kidney Transplant III: Nursing Management
Pharmacokinetics in Pediatric Patients: Drug Metabolism